GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » E10

Hamlet BioPharma AB publ (XSAT:HAMLET B) E10 : kr-0.20 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hamlet BioPharma AB publ's adjusted earnings per share data for the three months ended in Mar. 2025 was kr-0.070. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-0.20 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-07-01), Hamlet BioPharma AB publ's current stock price is kr4.125. Hamlet BioPharma AB publ's E10 for the quarter that ended in Mar. 2025 was kr-0.20. Hamlet BioPharma AB publ's Shiller PE Ratio of today is .


Hamlet BioPharma AB publ E10 Historical Data

The historical data trend for Hamlet BioPharma AB publ's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ E10 Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -0.18

Hamlet BioPharma AB publ Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 -0.18 -0.18 -0.19 -0.20

Competitive Comparison of Hamlet BioPharma AB publ's E10

For the Biotechnology subindustry, Hamlet BioPharma AB publ's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamlet BioPharma AB publ's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hamlet BioPharma AB publ's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hamlet BioPharma AB publ's Shiller PE Ratio falls into.


;
;

Hamlet BioPharma AB publ E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hamlet BioPharma AB publ's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.07/132.8245*132.8245
=-0.070

Current CPI (Mar. 2025) = 132.8245.

Hamlet BioPharma AB publ Quarterly Data

per share eps CPI Adj_EPS
201506 -0.003 99.995 -0.004
201509 -0.009 100.228 -0.012
201512 -0.022 100.276 -0.029
201603 -0.012 100.751 -0.016
201606 -0.023 101.019 -0.030
201609 -0.014 101.138 -0.018
201612 -0.030 102.022 -0.039
201703 -0.072 102.022 -0.094
201706 -0.026 102.752 -0.034
201709 -0.042 103.279 -0.054
201712 -0.036 103.793 -0.046
201803 -0.055 103.962 -0.070
201806 -0.035 104.875 -0.044
201809 -0.031 105.679 -0.039
201812 -0.034 105.912 -0.043
201903 -0.041 105.886 -0.051
201906 -0.067 106.742 -0.083
201909 -0.027 107.214 -0.033
201912 -0.077 107.766 -0.095
202003 -0.059 106.563 -0.074
202006 -0.061 107.498 -0.075
202009 -0.018 107.635 -0.022
202012 -0.027 108.296 -0.033
202103 -0.022 108.360 -0.027
202106 -0.007 108.928 -0.009
202109 -0.018 110.338 -0.022
202112 -0.026 112.486 -0.031
202203 -0.038 114.825 -0.044
202206 -0.068 118.384 -0.076
202209 -0.049 122.296 -0.053
202212 -0.054 126.365 -0.057
202303 -0.050 127.042 -0.052
202306 -0.027 129.407 -0.028
202309 -0.070 130.224 -0.071
202312 -0.073 131.912 -0.074
202403 -0.098 132.205 -0.098
202406 -0.069 132.716 -0.069
202409 -0.061 132.304 -0.061
202412 -0.081 132.987 -0.081
202503 -0.070 132.825 -0.070

Add all the adjusted EPS together and divide 10 will get our e10.


Hamlet BioPharma AB publ  (XSAT:HAMLET B) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Hamlet BioPharma AB publ E10 Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamlet BioPharma AB publ Business Description

Traded in Other Exchanges
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines